Veronica van Nederveen

Veronica van Nederveen

The complete DNA test provides a complete overview of all potential targeted cancer treatments. The patient and the attending physician have all available information to make a treatment decision.

Back to news

More news

Oncoanalyser 3.0 for cancer genomics is out, now supporting Illumina, Ultima Genomics & Roche platforms

Oncoanalyser 3.0 for cancer genomics is out, now supporting Illumina, Ultima Genomics & Roche platforms

04-09-2026

Extensive work on the underlying WiGiTS tools now enable users to analyze sequencing data from three sequencing platforms (Illumina, Ultima …

Hartwig and Ultima Expand Collaboration to Advance WGS in Oncology Care 

Hartwig and Ultima Expand Collaboration to Advance WGS in Oncology Care 

12-06-2026

Hartwig and Ultima strengthen collaboration on whole‑genome sequencing  Hartwig Medical Foundation to adopt Ultima Genomics’ UG200 sequencing system to accelerate …

Actionable metastatic cancer genome is remarkably stable over time, despite treatment with drugs

Actionable metastatic cancer genome is remarkably stable over time, despite treatment with drugs

10-08-2021

A one-time analysis of the entire tumor DNA is almost always sufficient to find all DNA errors that may be …

Would you like to be kept up to date with new developments?

Sign up for our newsletters

Want to know more about the complete DNA test?

Visit OncoAct.nl